SCHEMBL16260141

SCHEMBL16260141

CC(C)NCCCNCCCNCCCN

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.55
CA6 P23280 5/20 0.55
CA7 P43166 5/20 0.55
CA9 Q16790 5/20 0.55
CA14 Q9ULX7 5/20 0.55
CA5B Q9Y2D0 5/20 0.55
CA2 P00918 4/20 0.55
CA4 P22748 4/20 0.55
CA5A P35218 4/20 0.55
ALOX15 P16050 3/20 0.55
CASP2 P42575 2/20 0.55
F13A1 P00488 2/20 0.55
CYP1A2 P05177 2/20 0.55
THPO P40225 2/20 0.55
MEN1 O00255 2/20 0.55
RECQL P46063 2/20 0.55
KMT2A Q03164 2/20 0.55
CYP2C19 P33261 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CA3 P07451 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16260139 1.00 CA12 (0.55) CA12CA6CA7CA9CA14
SCHEMBL14522871 0.98 CA12 (0.59) CA12CA6CA7CA9CA14
SCHEMBL19240898 0.93 CA12 (0.56) CA12CA6CA7CA9CA14
SCHEMBL364371 0.90
SCHEMBL19086825 0.88 CA12 (0.56) CA12CA6CA7CA9CA14
Hydrochloric Acid SCHEMBL10636393 0.87 UBE2N (0.46) CA12CA6CA7CA9CA14
SCHEMBL25565749 0.87 CYP2C19 (0.45) CA12CA6CA7CA9CA14
SCHEMBL24001448 0.86 CA12 (0.52) CA12CA6CA7CA9CA14
SCHEMBL27105697 0.86 CA12 (0.50) CA12CA6CA7CA9CA14
SCHEMBL21565017 0.86 CA12 (0.43) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11697693-B2 Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-07-11 US disclosed
US-11672818-B2 Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-06-13 US disclosed
US-11672818-B2 Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-06-13 US disclosed
US-20230174679-A1 NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2023-06-08 US disclosed
US-20230174679-A1 NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2023-06-08 US disclosed
US-11421044-B2 Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2022-08-23 US disclosed
US-20210347918-A1 NITRIC OXIDE-RELEASING ALGINATES AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2021-11-11 US disclosed
US-20210346424-A1 NITRIC OXIDE-RELEASING CYCLODEXTRINS AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2021-11-11 US disclosed
US-11026965-B2 Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2021-06-08 US disclosed
US-20200216571-A1 NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2020-07-09 US disclosed
US-20190343869-A1 NITRIC OXIDE-RELEASING CYCLODEXTRINS AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2019-11-14 US disclosed
WO-2019173539-A1 NITRIC OXIDE-RELEASING CYCLODEXTRINS AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2019-09-12 WO disclosed
US-20190002429-A1 Derivatives of Xanthone Compounds SINGAPORE HEALTH SERVICES PTE LTD (SG) 2019-01-03 US disclosed
US-20140349918-A1 DERIVATIVES OF XANTHONE COMPOUNDS SINGAPORE HEALTH SERVICES PTE LTD. (SG) 2014-11-27 US disclosed
US-20140349918-A1 DERIVATIVES OF XANTHONE COMPOUNDS SINGAPORE HEALTH SERVICES PTE LTD. (SG) 2014-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190002429-A1 Derivatives of Xanthone Compounds XDH, XPA, SQLE CA12 4592/4885CA6 3725/4885CA7 4122/4885
US-20230174679-A1 NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO NOS2, NOS3, NOS1 CA12 3584/4885CA6 1006/4885CA7 1735/4885
US-20200216571-A1 NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO NOS2, NOS3, NOS1 CA12 3584/4885CA6 1006/4885CA7 1735/4885
US-20190343869-A1 NITRIC OXIDE-RELEASING CYCLODEXTRINS AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO NOS1, NOS2, NOS3 CA12 3440/4885CA6 1791/4885CA7 1562/4885
US-20210347918-A1 NITRIC OXIDE-RELEASING ALGINATES AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO NOS1, NOS2, NOS3 CA12 4376/4885CA6 2338/4885CA7 1675/4885
US-20140349918-A1 DERIVATIVES OF XANTHONE COMPOUNDS XDH, XPA, SQLE CA12 4592/4885CA6 3725/4885CA7 4122/4885
US-11672818-B2 Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto NOS1, NOS2, NOS3 CA12 3440/4885CA6 1791/4885CA7 1562/4885
US-11026965-B2 Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto NOS1, NOS2, NOS3 CA12 3440/4885CA6 1791/4885CA7 1562/4885
US-11697693-B2 Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto NOS1, NOS2, NOS3 CA12 4376/4885CA6 2338/4885CA7 1675/4885
US-11421044-B2 Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto NOS2, NOS3, NOS1 CA12 3584/4885CA6 1006/4885CA7 1735/4885
US-20210346424-A1 NITRIC OXIDE-RELEASING CYCLODEXTRINS AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO NOS1, NOS2, NOS3 CA12 3440/4885CA6 1791/4885CA7 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.